Are There Racial Differences in Inpatient Outcomes and Treatment Utilization Following Hospitalization for Myasthenia Gravis Exacerbation?

In this study, we used a claim-based database to assess racial differences in outcomes in hospitalized myasthenics. Methods The 2006 to 2014 National Inpatient Sample (NIS) database was queried using the International Classification of Diseases 9th Edition (ICD-9) diagnosis code (358.01) to identify adult patients (age>17 years) undergoing hospitalization for MG. Race was categorized into – White, Black/African American, Asian or Pacific Islander, Hispanic, Native American, and other. Complications assessed included urinary tract infections, acute renal failure, cardiac complications, systemic infection, deep venous thrombosis, and pulmonary embolism. Multivariate logistic regressi on analyses were used to assess whether race was associated with a difference in outcomes, after controlling for baseline demographics, hospital characteristics and treatment factors. For regression purposes, White race was used as the reference. Results A total of 56,189 patient admissions, using a weighted sample, underwent hospitalization for MG between 2006 to 2014. Black/ African American patients had significantly higher odds of experiencing systemic infections (OR 1.35 [95% CI 1.16-1.58]; p
Source: Neuroepidemiology - Category: Epidemiology Source Type: research